Post-Transplant Cyclophosphamide Is Associated with Improved Overall Survival and Reduced Non-Relapse Mortality When Compared with Alemtuzumab in Patients Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning: A Single Center Retrospective Analysis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Herman J. van Besien, Bayleigh Carver, Michelle S Pasciolla, David M. Salerno, Neela Easton, Alexandra Gómez Arteaga, Joshua Alexander Fein, Samuel Yamshon, Rachel Abramova, Nora Chokr, Gaurav Varma, Sebastian Mayer
+5 more Amer Assal, Tsiporah B. Shore, Koen van Besien, Juliet N. Barker, Anna Alperovich
DOI: 10.1016/j.jtct.2025.12.387
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S271–S272
Publication date
1 February 2026
Language
EN